Casi Pharmaceuticals Inc Reports Results For The Quarter Ended In September: Earnings Summary

CASI Pharmaceuticals

12/11/2021 14:31

* CASI Pharmaceuticals Inc  CASI.OQ  reported a quarterly
adjusted loss of 7 cents​​ per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for a loss of 5 cents per share.
* Revenue rose 91.2% to $8.11 million from a year ago;  analysts
expected $7.54 million. 
* CASI Pharmaceuticals Inc's reported EPS for the quarter was a
loss of 7 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* CASI Pharmaceuticals Inc shares had fallen by 11.8% this
quarter and lost 64.4% so far this year.
* The company reported a quarterly loss of $10.22 million.
* Wall Street's median 12-month price target for CASI
Pharmaceuticals Inc is $4.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 12 at 02:31 p.m.
 ​All figures in US dollars unless otherwise stated